Page 30 - Multiple System Atrophy News Today

Clara Fire Crew have come to the rescue of a local man with rapidly failing health. 50-year-old George Meares was recently diagnosed with Multiple System Atroph...

Publication in Presents to MST Access Australian Micro & Small Caps Conference Cash balance at 30 June 2021 of A$28M MELBOURNE, Australia, July 30, 2021 /PRNewswire/ — Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, releases its Appendix 4C Quarterly Cash Flow Report and update on company activities for the quarter ending 30 June 2021 (Q4 FY21...

.......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... In this 1996 photo, coach Mike Brown and Chargers player Shawn McConkey try to get a referee’s attention during a game against Socorro in Las Cruces. (Greg Sorber/Albuquerque Journal File) If you wanted to know Mike Brown but never had the chance, one could learn much – maybe everything – about...

Alterity Therapeutics Limited Received European Union Regulatory Guidance for ATH434 Phase 2 Clinical Trial Highlights: Alterity receives positive guidance from the European Medicines Agency’s Committee for Medicinal Products for Human Use on its Phase 2 clinical trial for Multiple System Atrophy. Concurrence with Alterity’s plan to target early stage MSA patients. Endorsement on selection of biomarker endpoints to assess pathological hallmarks of MSA. Agreement that ATH434 has potential...

Share: Pune, India, June 01, 2021 (GLOBE NEWSWIRE) -- The global neurological movement disorders market has been estimated to reach a value of USD 12,800 million in 2021 and is projected to grow at a CAGR of 9.80% during the forecast period from 2021 to 2030. Neurological movement disorders are conditions that impair ones ability to generate and regulate movement. This condition predominantly affects the brain, spinal cord, as well as nerves in the body, resulting in cerebrovascular diseases,...

Forthwith, time to put a bow on the week. ALL HAIL THE CHAMPS: Among the 10 classification winners were a pair of first-timers — the boys from Del Norte (Class 4A), and the 5A boys from Cleveland. Well, maybe it’s 2½ first-timers, since Roy’s girls had won state before, but not Mosquero. That co-op led to a championship last week, but they have to share a trophy. Navajo Prep’s girls repeated, Gallup’s girls were back on top for the first time in a decade, Hot Springs’ boys and Peco...

Why the Alterity (ASX:ATH) share price is skyrocketing 42% today Aaron Teboneras | April 21, 2021 3:56pm | More on: One of the best performers on the ASX today is the At the time of writing, Alterity shares are swapping hands for 4.25 cents apiece, up 41.67%. What does Alterity do? Alterity is an Australian biotech company focused on commercialising research into neurodegenerative disorders. These include Parkinsonian movement disorders, Alzheimer’s disease, Huntington disease and others. ...

ATH434 protects brain cells and improves motor function in Parkinsonian disorder Oral presentation at the American Academy of Neurology News provided by Share this article MELBOURNE, Australia  , April 21, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH,NASDAQ: ATHE) ("Alterity" or "the Company") today announced an oral presentation of expanded animal data to support the commercialisation of its lead compound ATH434 in clinical development for the treatment of Parkinsonian disorders, at t...

Clare FM 19th April 2021 In a deeply personal memoir, What Matters Now, he tells his story of love and hope. From the moments after his doctor uttered the words Multiple System Atrophy – a neurological disease that is both progressive and incurable, and ultimately carries a fatal prognosis – to how, drawing on inner reserves and determination, he pulled himself from the darkness to come to terms with a new way of living, his memoir bares all. CONTINUE READING BELOW

Gov. Kelly spreads awareness for Multiple System Atrophy Jayden Smith/Salina Journal Governor Laura Kelly officially proclaimed March to be Multiple System Atrophy (MSA) Awareness month in the state of Kansas Monday, adding the state to a small list of entities that recognize the distinction. MSA, previously known as Shy-Drager Syndrome, is a rare, deadly neurodegenerative condition that affects up to 50,000 Americans. Only 15,000 are currently diagnosed with the disease. Gregg Root of Abil...